AMARANTHINE LABS LTD

Executive Summary

AMARANTHINE LABS LTD currently operates as a dormant entity with minimal financial activity and negligible assets, reflected in a financial health score of D. While legally compliant and stable, the company shows no signs of active trading or cash flow generation. Strategic decisions on whether to activate, restructure, or close the business will be critical to improving its financial vitality going forward.

AMARANTHINE LABS LTD - Analysis Report

Company Number: 14263174

Analysis Date: 2025-07-20 13:00 UTC

Financial Health Assessment for AMARANTHINE LABS LTD

---

1. Financial Health Score: D

Explanation:
AMARANTHINE LABS LTD is currently classified as a dormant company with minimal financial activity and a consistently negligible balance sheet value (£1 in net assets and cash). While being dormant implies no active trading or financial transactions, this status limits the company’s operational vitality. The score of D reflects the company’s inactive financial state rather than insolvency or distress, indicating a "paused" rather than "ill" condition.

---

2. Key Vital Signs

Metric	Value	Interpretation
Company Status	Active, Dormant	Registered and operational legally, but no trading activity.
Cash at Year End	£1	Minimal liquidity, essentially no cash flow.
Net Assets	£1	Very low asset base, no business assets or equity growth.
Shareholders’ Funds	£1	Reflects nominal share capital only, no retained earnings.
Account Category	Dormant	No significant transactions, exempt from full accounting.
Filing Compliance	Up to date	No overdue accounts or returns filings.
Industry SIC Codes	IT consultancy, software development	Intended sectors but currently inactive financially.

---

3. Diagnosis: What the Financial Data Reveals

AMARANTHINE LABS LTD displays the "symptoms" of a dormant company. The core indicators—extremely low cash and net assets, absence of trading activity, and dormant account filings—point to a business that is essentially in hibernation. There is no evidence of operational revenue generation or asset accumulation.

This "financial heartbeat" is flat, reflecting no current business activity. While the company remains legally active and compliant with statutory reporting deadlines (no overdue filings), the absence of financial movement means it is not contributing economically or generating cash flow. This is akin to a patient who is stable but immobilized, with no active metabolic processes indicating growth or health.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

• Activate Operations Deliberately: If the company intends to trade, it should prepare for operational startup by securing capital injection, preparing business plans, and initiating sales or contracts. This will "jump-start" the financial metabolism.

• Maintain Compliance Vigilantly: Continue filing dormant accounts timely to avoid penalties and maintain good standing.

• Review Business Strategy: Consider whether remaining dormant aligns with long-term goals or if restructuring, sale, or formal closure might be appropriate to avoid ongoing administrative costs.

• Financial Planning: Upon activation, establish proper cash flow management and build working capital to ensure "healthy circulation" of funds.

• Monitor Market Opportunities: Given the IT and software focus, keep abreast of industry trends to determine optimal timing for business reactivation.

---